Welsh, Carson, Anderson & Stowe and Walgreen Co. Invest in Shields Health Solutions
July 31, 2019
Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. (Walgreens) made undisclosed equity investments in Shields Health Solutions to support the company’s national expansion and growth of its integrated specialty pharmacy model. The capital will help Shields expand into new disease states and enhance integrated service and technology offerings while accelerating partnerships with health systems nationwide.
- Buyers
- Welsh, Carson, Anderson & Stowe (WCAS), Walgreen Co. (Walgreens)
- Targets
- Shields Health Solutions
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Walgreens Boots Alliance Acquires Remaining Stake in Shields Health Solutions
September 20, 2022
Healthcare Services
Walgreens Boots Alliance entered into a definitive agreement to acquire the remaining ~30% stake in Shields Health Solutions for approximately $1.37 billion, completing WBA's move to full ownership of the specialty pharmacy integrator. Shields, a health system–focused specialty pharmacy accelerator headquartered in Stoughton, Massachusetts, has rapidly grown revenue and partnerships and will continue operating as a distinct business within Walgreens under new leadership.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in Leiters
November 9, 2021
Pharmaceuticals
Welsh, Carson, Anderson & Stowe (WCAS) acquired a majority ownership stake in Leiters, an FDA-registered 503B outsourced pharmaceutical compounding provider. WCAS invested alongside health system investors including Intermountain Ventures, Novant Health, Rex Health Ventures, Spectrum Health Ventures and UNC Health, while existing investors — including Kaiser Permanente Ventures, Mayo Clinic, Frazier Healthcare Partners, SV Health Investors and H.I.G. BioHealth Partners — made reinvestments to support Leiters' growth, facility expansion and new product development.
-
Welsh, Carson, Anderson & Stowe Acquires Majority Stake in GovernmentCIO
November 2, 2020
IT Services
Welsh, Carson, Anderson & Stowe (WCAS) completed a strategic majority investment in GovernmentCIO, a provider of technology and digital solutions to the federal health IT market. The investment will fund organic growth and support a buy-and-build strategy to expand GovernmentCIO’s capabilities and customer footprint across federal health and adjacent federal IT markets.
-
Welsh, Carson, Anderson & Stowe Acquires Green Street Advisors from Golden Gate Capital
June 3, 2019
Data & Analytics
Welsh, Carson, Anderson & Stowe (WCAS) has signed a definitive agreement to acquire Green Street Advisors from Golden Gate Capital. Management will reinvest and WCAS plans to accelerate organic growth, invest in product innovation and pursue strategic M&A to expand Green Street's research, data and analytics offerings for the commercial real estate market.
-
Welsh, Carson, Anderson & Stowe Invests in Constitution Surgery Alliance
June 16, 2025
Healthcare Services
Welsh, Carson, Anderson & Stowe (WCAS) has made a strategic growth investment in Constitution Surgery Alliance (CSA), an independent developer and operator of ambulatory surgery centers. The investment will provide capital and healthcare scaling expertise to help CSA expand nationally; CSA currently manages 16 facilities across five states and performs over 100,000 procedures annually.
-
Welsh, Carson, Anderson & Stowe Makes Strategic Growth Investment in ImageTrend, Inc.
February 10, 2023
Software
Welsh, Carson, Anderson & Stowe (WCAS) made an equity growth investment in ImageTrend, Inc., a market-leading provider of public safety and healthcare software, to accelerate growth and product innovation. WCAS partners with ImageTrend’s management and will add investment team members to the board to support continued expansion of the company’s software, analytics, and services across EMS, hospitals, fire, and public safety end markets.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.